WallStreetZenWallStreetZen

NASDAQ: STIM
Neuronetics Inc Stock Forecast, Predictions & Price Target

Analyst price target for STIM

Based on 1 analyst offering 12 month price targets for Neuronetics Inc.
Min Forecast
$8.00+107.25%
Avg Forecast
$8.00+107.25%
Max Forecast
$8.00+107.25%

Should I buy or sell STIM stock?

Based on 1 analyst offering ratings for Neuronetics Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their STIM stock forecasts and price targets.

STIM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-06Find Out Why

1 of 1

Forecast return on equity

Is STIM forecast to generate an efficient return?
Company
N/A
Industry
0.02%
Market
19.68%

Forecast return on assets

Is STIM forecast to generate an efficient return on assets?
Company
N/A
Industry
0.02%

STIM revenue forecast

What is STIM's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$78.9M+10.64%
Avg 2 year Forecast
$87.9M+23.23%
Avg 3 year Forecast
$96.6M+35.36%
STIM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

STIM revenue growth forecast

How is STIM forecast to perform vs Diagnostics & Research companies and vs the US market?
Company
10.95%
Industry
6%
Market
9.3%
STIM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
STIM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

STIM vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
STIM$3.86$8.00+107.25%Strong Buy
FONR$16.01N/AN/A
BDSX$1.28$3.50+173.44%Strong Buy
NOTV$4.85$18.25+276.29%Strong Buy
PRPH$5.16$11.00+113.18%Buy

Neuronetics Stock Forecast FAQ

Is Neuronetics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: STIM) stock is to Strong Buy STIM stock.

Out of 1 analyst, 1 (100%) are recommending STIM as a Strong Buy, 0 (0%) are recommending STIM as a Buy, 0 (0%) are recommending STIM as a Hold, 0 (0%) are recommending STIM as a Sell, and 0 (0%) are recommending STIM as a Strong Sell.

If you're new to stock investing, here's how to buy Neuronetics stock.

What is STIM's revenue growth forecast for 2024-2026?

(NASDAQ: STIM) Neuronetics's forecast annual revenue growth rate of 10.95% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 6%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.3%.

Neuronetics's revenue in 2024 is $71,348,000.On average, 2 Wall Street analysts forecast STIM's revenue for 2024 to be $2,348,942,824, with the lowest STIM revenue forecast at $2,341,801,371, and the highest STIM revenue forecast at $2,356,084,277. On average, 2 Wall Street analysts forecast STIM's revenue for 2025 to be $2,616,152,180, with the lowest STIM revenue forecast at $2,607,820,485, and the highest STIM revenue forecast at $2,624,483,875.

In 2026, STIM is forecast to generate $2,873,839,599 in revenue, with the lowest revenue forecast at $2,873,839,599 and the highest revenue forecast at $2,873,839,599.

What is STIM's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: STIM) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 0.02%.

What is STIM's Price Target?

According to 1 Wall Street analyst that have issued a 1 year STIM price target, the average STIM price target is $8.00, with the highest STIM stock price forecast at $8.00 and the lowest STIM stock price forecast at $8.00.

The Wall Street analyst predicted that Neuronetics's share price could reach $8.00 by Mar 6, 2025. The average Neuronetics stock price prediction forecasts a potential upside of 107.25% from the current STIM share price of $3.86.

What is STIM's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: STIM) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.